Bg pattern

BEYONTTRA 356 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use BEYONTTRA 356 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

BEYONTTRA 356 mg film-coated tablets

acoramidis

This medicinal product is subject to additional monitoring, which will allow for quick identification of new safety information. You can help by reporting any side effects you may get. The last section of this leaflet includes information on how to report side effects.

Read all of this leaflet carefully before you start taking this medicine, because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is BEYONTTRA and what is it used for
  2. What you need to know before you take BEYONTTRA
  3. How to take BEYONTTRA
  4. Possible side effects
  5. Storage of BEYONTTRA
  6. Contents of the pack and other information

1. What is BEYONTTRA and what is it used for

BEYONTTRA contains the active substance acoramidis (as hydrochloride).

It is used to treat adults who have a cardiomyopathy (a disease that affects the heart muscle) caused by transthyretin amyloidosis (ATTR-CM).

In people with transthyretin amyloidosis, a protein called transthyretin (TTR) does not work properly, causing it to break down and form a buildup of fibers called amyloids. When amyloids build up in the heart, the heart muscle becomes stiff and the heart stops working properly. BEYONTTRA stabilizes TTR, which can prevent it from breaking down and forming amyloids. This helps people whose hearts have been affected by transthyretin amyloid cardiomyopathy.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take BEYONTTRA

Do not take BEYONTTRA

If you are allergic to acoramidis or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Tell your doctor, pharmacist, or nurse before starting BEYONTTRA, especially if you have liver or severe kidney problems.

When starting treatment, you may experience changes in blood tests for kidney function, although these changes should not negatively affect your kidneys.

Children and adolescents

BEYONTTRA is not used in children and adolescents. Its use has not been studied in this population.

Other medicines and BEYONTTRA

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

BEYONTTRA may affect thyroid blood tests, although these changes should not negatively affect your thyroid function.

Pregnancy, breastfeeding, and fertility

If you are pregnant, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine, as it is not known whether BEYONTTRA can harm the fetus.

It is not known whether this medicine passes into breast milk. If you are breastfeeding or plan to breastfeed, consult your doctor or pharmacist before using this medicine. There are no data on the use of BEYONTTRA in pregnant women.

Driving and using machines

BEYONTTRA has no or negligible influence on your ability to drive and use machines.

Sodium

This medicine contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially "sodium-free".

3. How to take BEYONTTRA

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.

The recommended dose is two film-coated tablets (712 mg) taken orally twice a day. The total daily dose is 1,424 mg of acoramidis.

The tablets should be swallowed whole. They can be taken with water and with or without food.

If you take more BEYONTTRA than you should

Do not take more tablets than your doctor has told you. Contact your doctor if you think you have taken more tablets than you should.

If you forget to take BEYONTTRA

If you forget to take the tablets, take them at the next scheduled time. Do not take a double dose to make up for forgotten doses.

If you stop taking BEYONTTRA

Do not stop taking BEYONTTRA without consulting your doctor first. If you stop taking BEYONTTRA, your disease may progress.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Possible side effects are:

Very common (may affect more than 1 in 10 people)

  • Diarrhea
  • Painful inflammation of the joints (gout)

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of BEYONTTRA

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date is the last day of the month shown.

This medicine does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

What BEYONTTRA contains

  • The active substance is acoramidis (as hydrochloride). Each tablet contains hydrochloride equivalent to 356 mg of acoramidis.
  • The other ingredients are: microcrystalline cellulose (E 460), sodium croscarmellose (E 468), colloidal hydrated silica (E 551), magnesium stearate (E 470b), macrogol/polyvinyl alcohol grafted copolymer (E 1209), talc (E 553b), titanium dioxide (E 171), glycerol monocaprylocaprate type I (E 471), polyvinyl alcohol (E 1203), black iron oxide (E 172), propylene glycol (E 1520), hypromellose 2910 (E 464).
  • See section 2 for information on sodium.

Appearance and packaging

BEYONTTRA 356 mg film-coated tablets are oval, white tablets, approximately 15 mm x 7.5 mm, with the company logo BridgeBio followed by "ACOR" printed in black ink on one side.

BEYONTTRA is available in double-cavity PVC/PCTFE blisters sealed with an aluminum foil in a pack containing 120 tablets.

Marketing authorisation holder

Manufacturer

Bayer AG

51368 Leverkusen

Germany

Rottendorf Pharma GmbH

Ostenfelder Strasse 51-61

Ennigerloh, 59320

Germany

You can request more information about this medicine from the local representative of the marketing authorisation holder:

België/Belgique/Belgien

Bayer SA-NV

Tél/Tel: +32-(0)2-535 63 11

Lietuva

UAB Bayer

Tel. +37 05 23 36 868

Text in Bulgarian language showing company name Байер България ЕООД and phone number +359 (0)2 4247280

Luxembourg/Luxemburg

Bayer SA-NV

Tél/Tel: +32-(0)2-535 63 11

Ceská republika

Bayer s.r.o.

Tel: +420 266 101 111

Magyarország

Bayer-Hungária Kft.

Tel.: +36 1 487 4100

Danmark

Bayer A/S

Tlf.: +45 45 23 50 00

Malta

Alfred Gera and Sons Ltd.

Tel: +35 621 44 62 05

Deutschland

Bayer Vital GmbH

Tel: +49 (0)214-30 513 48

Nederland

Bayer B.V.

Tel: +31-23 – 799 1000

Eesti

Bayer OÜ

Tel: +372 655 8565

Norge

Bayer AS

Tlf: +47 23 13 05 00

Ελλáδα

Bayer Ελλáς ΑΒΕΕ

Τηλ: +30-210-61 87 500

Österreich

Bayer Austria Ges.m.b.H.

Tel: +43-(0)1-711 46-0

España

Bayer Hispania S.L.

Tel: +34-93-495 65 00

Polska

Bayer Sp. z o.o.

Tel.: +48 22 572 35 00

France

Bayer HealthCare

Tél (N° vert): +33-(0)800 87 54 54

Portugal

Bayer Portugal, Lda.

Tel: +351 21 416 42 00

Hrvatska

Bayer d.o.o.

Tel: +385-(0)1-6599 900

România

SC Bayer SRL

Tel: +40 21 529 59 00

Ireland

Bayer Limited

Tel: +353 1 216 3300

Slovenija

Bayer d. o. o.

Tel: +386 (0)1 58 14 400

Ísland

Icepharma hf.

Sími: +354 540 8000

Slovenská republika

Bayer spol. s r.o.

Tel. +421 2 59 21 31 11

Italia

Bayer S.p.A.

Tel: +39 02 397 8 1

Suomi/Finland

Bayer Oy

Puh/Tel: +358- 20 785 21

Κúπρος

NOVAGEM Limited

Τηλ: +357 22 48 38 58

Sverige

Bayer AB

Tel: +46 (0) 8 580 223 00

Latvija

SIA Bayer

Tel: +371 67 84 55 63

Date of last revision of this leaflet:

Other sources of information

Detailed information on this medicine is available on the European Medicines Agency website: https://www.ema.europa.eu.

Online doctors for BEYONTTRA 356 mg FILM-COATED TABLETS

Discuss questions about BEYONTTRA 356 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (2)
Doctor

Svetlana Kolomeeva

Cardiology 18 years exp.

Dr. Svetlana Kolomeeva is a general practitioner and internal medicine doctor providing online consultations for adults. She helps patients manage acute symptoms, chronic conditions, and preventive care. Her clinical focus includes cardiovascular health, hypertension control, and managing symptoms like fatigue, weakness, sleep issues, and overall low energy.

Patients commonly seek her help for:

  • High blood pressure, headaches, dizziness, swelling, palpitations.
  • Diagnosis and management of hypertension, arrhythmias, and tachycardia.
  • Metabolic syndrome, excess weight, high cholesterol.
  • Chronic fatigue, insomnia, poor concentration, anxiety.
  • Respiratory symptoms: colds, flu, sore throat, cough, fever.
  • Digestive issues: heartburn, bloating, constipation, IBS symptoms.
  • Chronic conditions: diabetes, thyroid disorders.
  • Interpretation of lab tests and medical reports, therapy adjustment.
  • Second opinion and decision-making support.
  • Cardiovascular disease prevention and metabolic risk reduction.
  • Long-term follow-up and dynamic health monitoring.

Dr Kolomeeva combines clinical expertise with personalised care. She clearly explains diagnoses, guides patients through symptoms and treatment options, and provides actionable plans. Her consultations are designed not only to address current complaints but also to stabilise chronic conditions and prevent future complications. She supports patients through every stage of care – from first symptoms to ongoing health management.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for BEYONTTRA 356 mg FILM-COATED TABLETS?
BEYONTTRA 356 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
Who manufactures BEYONTTRA 356 mg FILM-COATED TABLETS?
BEYONTTRA 356 mg FILM-COATED TABLETS is manufactured by Bayer Ag. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of BEYONTTRA 356 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether BEYONTTRA 356 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to BEYONTTRA 356 mg FILM-COATED TABLETS?
Other medicines with the same active substance () include ADENOCOR 6 mg/2 ml INJECTABLE SOLUTION, ADENOSCAN 30 mg/10 ml SOLUTION FOR INFUSION, ADENOSINE ACCORD 30 mg/10 mL SOLUTION FOR INFUSION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media